The transcription of fatty acid synthase (FAS), a central enzyme in de novo lipogenesis, is dramatically induced by fasting͞refeeding and insulin. We reported that upstream stimulatory factor binding to the ؊65 E-box is required for induction of the FAS transcription by insulin in 3T3-L1 adipocytes. On the other hand, we recently found that two upstream 5 regions are required for induction in vivo by fasting͞refeeding and insulin; one at ؊278 to ؊131 albeit at a low level, and the other at ؊444 to ؊278 with an E-box at ؊332 where upstream stimulatory factor functions for maximal induction. Here, we generated double transgenic mice carrying the chloramphenicol acetyltransferase reporter driven by the various 5 deletions of the FAS promoter region and a truncated active form of the sterol regulatory element (SRE) binding protein (SREBP)-1a. We found that SREBP participates in the nutritional regulation of the FAS promoter and that the region between ؊278 and ؊131 bp is required for SREBP function. We demonstrate that SREBP binds the ؊150 canonical SRE present between ؊278 and ؊131, and SREBP can function through the ؊150 SRE in cultured cells. These in vivo and in vitro results indicate that SREBP is involved in the nutritional induction of the FAS promoter via the ؊278͞؊131 region and that the ؊150 SRE is the target sequence. F atty acid synthase (FAS) plays a central role in de novo lipogenesis in mammals (1). By the action of its seven active sites, FAS catalyzes all of the reaction steps in the conversion of acetyl-CoA and malonyl-CoA to palmitate. FAS activity is not known to be regulated by allosteric effectors or covalent modification. However, FAS concentration is exquisitely sensitive to nutritional and hormonal status in lipogenic tissues, liver, and adipose tissue (1-3). FAS mRNA is not detectable in livers of fasted mice but refeeding a high-carbohydrate, fat-free diet increases FAS mRNA levels dramatically, because of the changes in transcription (4, 5). Increased circulating insulin and decreased glucagon levels may participate in the regulation of FAS expression. FAS gene transcription was not detectable in fasted or refed streptozotocin-diabetic mice but increased by insulin administration (5). We mapped an insulin response sequence to Ϫ71 to Ϫ50 bp that contains a core E-box (CAT-GTG) by transfection of serial 5Ј deletions of the FAS promoter fused to the luciferase (LUC) reporter gene into 3T3-L1 adipocytes (6, 7). Binding to the Ϫ65 E-box by upstream stimulatory factor (USF)1 and USF2, which belong to the basic helix-loophelix leucine zipper family of transcription factors, was required for the insulin-mediated induction of the FAS gene (6-8). We also demonstrated that the 2.1-kb 5Ј flanking sequence is sufficient for the tissue-specific and hormonal͞nutritional regulation of the FAS gene in the in vivo context. Recently, by generating transgenic mice bearing various 5Ј deletion FAS promoter-chloramphenicol acetyltransferase (CAT) genes, we found that, unlike in cultured cell system, two 5Ј promoter regions were required for such regulation in vivo. The first region, located between Ϫ278 and Ϫ131 bp, confers FAS promoter activation upon refeeding͞insulin treatment, but a second region, from Ϫ444 to Ϫ278 bp, is required for maximal activation similar to that observed in mice carrying the longer 2.1-kb FAS promoter region (9). We also demonstrated that USF binding to the Ϫ332 E-box may be responsible for high-level activation of the FAS promoter. Vaulont and coworkers (10) recently reported that in USF1 and USF2 knockout mice, induction of the FAS gene by a high-carbohydrate diet was severely impaired, demonstrating in vivo requirement for USFs for glucose͞insulin regulation. These in vivo and in vitro studies clearly demonstrate that USF is a key transcription factor involved in the nutritional͞hormonal regulation of the FAS gene.
The transcription of fatty acid synthase (FAS), a central enzyme in de novo lipogenesis, is dramatically induced by fasting͞refeeding and insulin. We reported that upstream stimulatory factor binding to the ؊65 E-box is required for induction of the FAS transcription by insulin in 3T3-L1 adipocytes. On the other hand, we recently found that two upstream 5 regions are required for induction in vivo by fasting͞refeeding and insulin; one at ؊278 to ؊131 albeit at a low level, and the other at ؊444 to ؊278 with an E-box at ؊332 where upstream stimulatory factor functions for maximal induction. Here, we generated double transgenic mice carrying the chloramphenicol acetyltransferase reporter driven by the various 5 deletions of the FAS promoter region and a truncated active form of the sterol regulatory element (SRE) binding protein (SREBP)-1a. We found that SREBP participates in the nutritional regulation of the FAS promoter and that the region between ؊278 and ؊131 bp is required for SREBP function. We demonstrate that SREBP binds the ؊150 canonical SRE present between ؊278 and ؊131, and SREBP can function through the ؊150 SRE in cultured cells. These in vivo and in vitro results indicate that SREBP is involved in the nutritional induction of the FAS promoter via the ؊278͞؊131 region and that the ؊150 SRE is the target sequence. F atty acid synthase (FAS) plays a central role in de novo lipogenesis in mammals (1) . By the action of its seven active sites, FAS catalyzes all of the reaction steps in the conversion of acetyl-CoA and malonyl-CoA to palmitate. FAS activity is not known to be regulated by allosteric effectors or covalent modification. However, FAS concentration is exquisitely sensitive to nutritional and hormonal status in lipogenic tissues, liver, and adipose tissue (1) (2) (3) . FAS mRNA is not detectable in livers of fasted mice but refeeding a high-carbohydrate, fat-free diet increases FAS mRNA levels dramatically, because of the changes in transcription (4, 5) . Increased circulating insulin and decreased glucagon levels may participate in the regulation of FAS expression. FAS gene transcription was not detectable in fasted or refed streptozotocin-diabetic mice but increased by insulin administration (5) . We mapped an insulin response sequence to Ϫ71 to Ϫ50 bp that contains a core E-box (CAT-GTG) by transfection of serial 5Ј deletions of the FAS promoter fused to the luciferase (LUC) reporter gene into 3T3-L1 adipocytes (6, 7) . Binding to the Ϫ65 E-box by upstream stimulatory factor (USF)1 and USF2, which belong to the basic helix-loophelix leucine zipper family of transcription factors, was required for the insulin-mediated induction of the FAS gene (6) (7) (8) . We also demonstrated that the 2.1-kb 5Ј flanking sequence is sufficient for the tissue-specific and hormonal͞nutritional regulation of the FAS gene in the in vivo context. Recently, by generating transgenic mice bearing various 5Ј deletion FAS promoter-chloramphenicol acetyltransferase (CAT) genes, we found that, unlike in cultured cell system, two 5Ј promoter regions were required for such regulation in vivo. The first region, located between Ϫ278 and Ϫ131 bp, confers FAS promoter activation upon refeeding͞insulin treatment, but a second region, from Ϫ444 to Ϫ278 bp, is required for maximal activation similar to that observed in mice carrying the longer 2.1-kb FAS promoter region (9) . We also demonstrated that USF binding to the Ϫ332 E-box may be responsible for high-level activation of the FAS promoter. Vaulont and coworkers (10) recently reported that in USF1 and USF2 knockout mice, induction of the FAS gene by a high-carbohydrate diet was severely impaired, demonstrating in vivo requirement for USFs for glucose͞insulin regulation. These in vivo and in vitro studies clearly demonstrate that USF is a key transcription factor involved in the nutritional͞hormonal regulation of the FAS gene.
In addition to USF, another basic helix-loop-helix transcription factor, sterol regulatory element (SRE) binding protein (SREBP), has been implicated in the regulation of the FAS gene. The Goldstein and Brown laboratory (11-13) showed higher mRNA levels for FAS, along with other lipogenic enzymes, in livers of transgenic mice expressing a truncated active form of SREBP, the induction being higher in SREBP-1a transgenic mice than in SREBP-2 transgenic mice. Furthermore, lipogenic enzyme gene induction during fasting͞refeeding was abolished in SREBP-1 knockout mice (14) . SREBP is an endoplasmic reticulum membrane-bound transcription factor that regulates various genes involved in cholesterol and fatty acid metabolism (15) . SREBP must be proteolytically cleaved to release the amino-terminal segment to generate the mature form, which can enter the nucleus (16) and bind to SREs, 5Ј-ATCACCCCAC-3Ј, in various promoters (17) (18) (19) (20) . Osborne and coworkers (21, 25) reported that suppression of FAS transcription by sterol is mediated by SREBP binding to the two tandem copies of SREs overlapping with the Ϫ65 E-box, which we previously showed to be a USF binding site for insulin regulation. Spiegelman and coworkers (22) , on the other hand, reported that SREBP can bind not only SRE but also E-box motif because of the presence of an atypical tyrosine residue in the conserved basic domain. By using a mutated SREBP that can bind only an E-box and not a consensus SRE, they reported that SREBP activated the FAS promoter by binding to the Ϫ65 E-box during nutritional and insulin regulation (23, 24) . In our hands, however, mutations around the E-box, which dramatically reduced SREBP but not USF binding to this region, did not affect insulin regulation of the FAS promoter in 3T3-L1 adipocytes (6). Furthermore, as described above, the first 131 bp of the FAS promoter that contains this Ϫ65 sequence could not confer nutritional and insulin regulation of the CAT reporter gene in transgenic mice (9) . Therefore, although studies on transgenic mice overexpressing SREBP suggest its role in the activation of the FAS promoter, SREBP binding site(s) in the FAS promoter or its precise role during the nutritional regulation of the FAS promoter are yet to be clarified.
To examine the potential role of SREBP in the nutritional regulation of the FAS promoter in vivo, we generated double transgenic mice containing a CAT reporter driven by the various 5Ј deletion of the FAS promoter, Ϫ131, Ϫ278, Ϫ444, Ϫ644, and Ϫ2,100 bp, along with SREBP-1a driven by the phosphoenolpyruvate carboxykinase (PEPCK) promoter. We show that SREBP activates the FAS promoter in vivo. The Ϫ131 FAS promoter, which contains the Ϫ71͞Ϫ54 region implicated for SREBP function in vitro (23, 25) , is not activated by SREBP in transgenic mice. SREBP, when overexpressed in fasted mice, activates the FAS promoter to the level found in refeeding only in the presence of an upstream region between Ϫ278 and Ϫ131 containing an SRE at Ϫ150 where SREBP can bind and transactivate in vitro. Maximal activation observed in refeeding, as we have shown previously, can be achieved only via a further upstream region between Ϫ444 and Ϫ278 containing an E-box at Ϫ332 where USF functions.
Materials and Methods
Plasmid Construction and Production of Transgenic Mice. Transgenic mice harboring the CAT gene driven by the various 5Ј deletions of the FAS promoter were generated, and the transgenic mice were identified by PCR of the tail DNA as described (9, 26) . We used a minimum of two independent founder lines for the different FAS promoter regions as previously described and essentially the same results were obtained. The B6SJL-SREBP-1a transgenic mice were obtained from The Jackson Laboratory (11) and bred with wild-type C57BL͞6 mice. The progenies were bred to the different FAS transgenic mice to generate various double FAS-CAT͞SREBP-1a transgenic mice. To identify the double-transgenic mice, the primers 5Ј-CATCCCTGTGACCCCTCC-3Ј and 5Ј-CTCCAAACCAC-CCCCCTC-3Ј were used to amplify a 151-bp fragment of the human growth hormone polyadenylation signal sequence, which is part of the SREBP-1a transgene. We used minimum of three F 1 double-transgene-positive male mice of 8-12 weeks of age for each 5Ј deletion FAS promoter-CAT for our studies.
The reporter gene constructs for Ϫ19 FAS-LUC, Ϫ136 FAS-LUC, Ϫ248 FAS-LUC, Ϫ318 FAS-LUC, and Ϫ2100 FAS-LUC, which contain, respectively, the Ϫ19͞ϩ67, Ϫ136͞ϩ67, Ϫ248͞ ϩ67, Ϫ318͞ϩ67, and Ϫ2100͞ϩ67 sequences of the rat FAS promoter fused to the LUC reporter plasmid p0Luc, have been described (27) (28) (29) . Ϫ2100(Ϫ65) FAS-LUC was generated by mutating Ϫ65͞Ϫ60 sequence to 5Ј-GAATTC-3Ј by site-directed mutagenesis (6) . Ϫ444 FAS-LUC was constructed by ligating the DraIII-HindIII fragment from the Ϫ2100 FAS-LUC plasmid containing sequences Ϫ444 to ϩ67 of the rat FAS gene into the promoterless vector p0LUC. Ϫ444(Ϫ65) FAS-LUC was constructed following the same procedure used for the Ϫ444 FAS-LUC construct but using the DraIII-HindIII fragment from Ϫ2100(Ϫ65) FAS-LUC plasmid. The constructs Ϫ136(Ϫ65)FAS-LUC and Ϫ184(Ϫ65)FAS-LUC were generated by ligating the AscI-BspDI fragment from Ϫ2100(65) FAS-LUC into the plasmids Ϫ136 FAS-LUC and Ϫ184 FAS-LUC previously cut with those same enzymes to eliminate the original E-box sequence. The Ϫ444͞ϩ67 FAS promoter fragment was subcloned into the pGL2 basic reporter vector by restriction digestion with XbaI. The plasmids Ϫ444(Ϫ150) FAS-LUC and Ϫ444(Ϫ65͞Ϫ150) FAS-LUC were constructed by mutating the Ϫ150͞Ϫ141 FAS sequence to 5Ј-ATCGATC-CAC-3Ј by site-directed mutagenesis. Ϫ444(Ϫ332) FAS-LUC, Ϫ444(Ϫ65͞Ϫ332) FAS-LUC, Ϫ444(Ϫ150͞Ϫ332) FAS-LUC and Ϫ444(Ϫ65͞Ϫ150͞Ϫ332) FAS-LUC plasmids were generated by mutating the Ϫ341͞Ϫ327 FAS sequence to 5Ј-AAGCTTCCAACGCGT-3Ј by using the same method used for the previous constructs. The heterologous promoter constructs were made by inserting one or six copies of the 5Ј-CGCGGGCATCACCCCACCGACGGC-3Ј sequence into the pGL2 promoter reporter vector. The expression vector for the truncated active form of SREBP-1a has been described (6).
Animal Treatments. The animals had access ad libitum to food pellets containing 58% carbohydrate. Before fasting͞refeeding experiments, the mice were fed a synthetic low-carbohydrate protein diet (no. 5789C; Purina) containing 71% (wt͞wt) casein and 4.25% (wt͞wt) sucrose for 2 weeks (11). Mice were fasted for 24 h, or fasted mice were refed a high-carbohydrate (58%), fat-free diet for 16 h.
Cell Culture and Transient Transfection Assays. 3T3-L1 fibroblasts were cultured in DMEM containing 10% FBS. For transient transfection of 3T3-L1 fibroblasts, 5 g of the experimental reporter plasmid with 25 ng of the SREBP-1a expression vector was cotransfected by using the calcium phosphate-DNA coprecipitation method along with 10 ng of the expression vector for cytomegalovirus-␤-galactosidase, used as a control for transfection efficiency. Control cells were cotransfected with 25 ng of pcDNA3.1 (Invitrogen). Cells were washed twice with PBS 16-18 h after transfection. Forty-eight hours after transfection, cells were harvested, and LUC and ␤-galactosidase activities were measured by using a Tropix kit (Dual-Light Reporter Gene Assay). Transfections were carried out in quadruplicate, and at least two different preparations for each plasmid were used.
RNA Isolation, Northern Blot Analysis, and Ribonuclease Protection
Assays. Tissues excised by rapid dissection and frozen in liquid nitrogen were pulverized by using a ceramic mortar and pestle. Total RNA was isolated from the frozen tissues by using TRIzol (GIBCO͞BRL) following the manufacturer's procedure. Northern blot and ribonuclease protection assays were carried out as described (9) . The plasmid pSREBP-1a (kindly provided by Michael S. Brown and Joseph L. Goldstein, Univ. of Texas Southwestern Medical Center, Dallas) containing a 4,154-bp fragment of the human SREBP-1a cloned into the EcoRI͞SalI restriction site in pBluescript II was used as a probe for Northern blot analysis.
In Vitro Transcription͞Translation of SREBP-1a. Plasmid DNA containing SREBP-1a sequence cloned in pcDNA3.1 (6) was digested with XbaI and in vitro-transcribed with T7 RNA polymerase. The RNA then was in vitro-translated by using rabbit reticulocyte lysates (Promega) by following the manufacturer's procedure. An in vitro translation reaction with no RNA added was used as the negative control. Parallel experiments were set up to allow one set of reactions to produce 35 S-Met-labeled protein to monitor the translation product and the other set of reactions to produce unlabeled protein for gel mobility shift assays.
Gel Mobility Shift Assay. The following single-stranded oligonucleotides were synthesized by GIBCO͞BRL: Ϫ65 E-Box: 5Ј-AGCTGTCAGCCCATGTGGCGTGGCCGC-3Ј, 3Ј-AGTC-GGGTACACCGCACCGGCGTCGAC-5Ј; Ϫ150 SR E:
Double-stranded oligonucleotides were formed as described (6) . All probes for gel shift assays were labeled by using [␣- 32 P] dCTP in the presence of dATP, dGTP, and dTTP, and Klenow fragment of Escherichia coli DNA polymerase. Cold dCTP was added at the end of the labeling reaction to make full-length probes. Reactions (20 l) containing the indicated amount of in vitro-translated SREBP-1a and 1 ϫ 10 7 cpm oligonucleotide probes were carried out at room temperature for 1 h and subjected to 6% nondenaturing PAGE, and autoradiography was performed as described (7) . For supershifting, specific SREBP-1 antibody (2 l per reaction; Santa Cruz Biotechnology) was added to the binding reactions for the final 30 min.
Results and Discussion
Involvement of SREBP in Nutritional Regulation of the FAS Promoter in Vivo. We previously reported that 2.1 kb of the 5Ј flanking sequence is sufficient for tissue-specific and nutritional͞ hormonal regulation of the FAS gene in vivo. We also showed that two promoter regions are required for maximal nutritional͞ insulin regulation of the FAS gene: one from Ϫ278 to Ϫ131 mediates induction by feeding and by insulin albeit at a low level, and the other from Ϫ444 to Ϫ278 is required for maximal induction. Furthermore, we demonstrated that USF binds to the Ϫ332 E-box present in the distal region and mediates maximal activation of the FAS promoter (9) . In addition to USF, SREBP may be involved in the regulation of the FAS promoter. The Goldstein and Brown laboratory (11, 12) showed that FAS mRNA levels, along with other lipogenic enzymes, are induced in livers of transgenic mice expressing a truncated active form of SREBP. SREBP-1 itself also is known to be induced in liver when animals were refed a high-carbohydrate diet, and SREBP-1c isoform recently has been shown to be selectively increased in liver by insulin treatment of diabetic animals (30, 31) . To examine the involvement of SREBP in the nutritional regulation of the FAS promoter in vivo, we have generated double transgenic mice carrying the CAT reporter gene driven by the 2.1 kb of the FAS promoter and a truncated active form of the SREBP-1a driven by the phosphoenolpyruvate carboxykinase (PEPCK) promoter (11) . Endogenous SREBP-1 mRNA levels were low in fasting and increased when animals were refed a high-carbohydrate, fat-free diet (the SREBP-1a sequence used as a probe detected both the SREBP-1a and Ϫ1c isoforms; ref. 32). The SREBP transgene was expressed at a high level only during fasting and was decreased to a very low level during feeding in FAS-CAT͞SREBP double transgenic mice (Fig. 1A) .
This result was predicted because, contrary to the lipogenic enzymes, the PEPCK promoter driving the transgene is activated in fasting and repressed during feeding. In SREBP transgenic mice, the endogenous SREBP mRNA levels were slightly increased in fasting to the level observed in refeeding, possibly because of activation of the SREBP promoter by the SREBP transgene product. As we showed previously, RNase protection analysis demonstrates undetectable CAT mRNA levels in livers of mice carrying Ϫ2100-FAS-CAT in fasting, which are dramatically induced in refeeding, in a fashion similar to the endogenous FAS mRNA levels (Fig. 1B) . In contrast, in SREBP or FAS-CAT͞SREBP transgenic mice, FAS mRNA levels were high even in fasting, probably because of the activation of the FAS promoter by the SREBP transgene product, which is highly expressed only in fasting. The induction of the FAS mRNA levels in these SREBP and FAS-CAT͞SREBP transgenic mice during feeding were similar to that of the FAS-CAT transgenic or wild-type mice. As expected, SREBP transgenic mice did not show any CAT expression. Similar to the FAS mRNA levels, FAS-CAT͞SREBP double transgenic mice showed high CAT mRNA levels in fasting similar to those observed in refeeding. This finding indicates that, because SREBP transgene is highly expressed only in fasting but not during feeding, the activation of the FAS promoter and the resultant increase in CAT mRNA levels in fasting to those observed in refeeding was caused by the SREBP transgene product. This also indicates that the 2.1 kb of the 5Ј flanking region of the FAS gene contains the regulatory elements required to achieve activation of the FAS promoter by SREBP.
Region Responsible for Activation of the FAS Promoter by SREBP
During Nutritional Regulation in Vivo. To examine the 5Ј flanking region(s) involved in the activation of the FAS gene by SREBP in vivo, transgenic mice carrying Ϫ644-, Ϫ444-, Ϫ278-and Ϫ131-FAS-CAT fusion genes (9) were bred to SREBP transgenic mice to obtain various FAS-CAT͞SREBP-1a double transgenic animals. Multiple founder lines were used because transgene expression can be affected by the location of genomic integration and copy number. The estimation of copy numbers for each founder line for the various FAS promoter-CAT fusion genes is as follows: Ϫ2.1 FAS-CAT (2 lines: 3 copies each); Ϫ644 FAS-CAT (1 line: 3 copies); Ϫ444 FAS-CAT (2 lines: 4 or 5 copies); Ϫ278 FAS-CAT (3 lines: 2 or 3 copies); and Ϫ131 FAS-CAT (4 lines; 1, 3, 4, or 5 copies). As expected, none of the FAS-CAT transgenic mice showed detectable FAS mRNA levels during fasting but all showed dramatically increased levels when refed (Fig. 2 Left) . As we reported previously and as in the 2.1-kb FAS-CAT transgenic mice shown in Fig. 1B , CAT mRNA levels in 5Ј deletion FAS-CAT transgenic mice were not detectable in fasting. Upon refeeding, CAT mRNA levels were dramatically increased in Ϫ644-and Ϫ444-FAS-CAT transgenic mice. In Ϫ278-FAS-CAT transgenic mice, the induction of CAT expres- Fig. 1. SREBP-1a activates the FAS promoter in vivo. (A) Northern blot analysis of both endogenous SREBP and SREBP transgene in Ϫ2100-FAS-CAT transgenic mice or Ϫ2100-FAS-CAT͞SREBP-1a transgenic animals. Transgenic mice were either fasted for 24 h or fasted for 24 h then refed a high-carbohydrate͞fat-free diet for 16 h. (B) mRNA levels for the endogenous FAS gene and CAT transgene analyzed by RNase protection assays using total liver RNA as described in Materials and Methods in transgenic mice carrying the Ϫ2100-FAS-CAT, the SREBP transgene, or both. Actin mRNA was used as a control. Essentially the same results were obtained from three independent experiments. F and R indicate fasted or refed states, respectively. sion by feeding was low, less than 10% of that observed in Ϫ644-and Ϫ444-FAS-CAT transgenic mice, whereas in Ϫ131-FAS-CAT transgenic mice CAT expression was not detectable even in feeding.
As shown with the 2.1-kb FAS-CAT͞SREBP transgenic mice, all FAS-CAT͞SREBP double transgenic mice showed high levels for endogenous FAS mRNA whether fasted or refed (Fig.  2 Right) . The high-level expression of the FAS mRNA during fasting, which is not observed in FAS-CAT transgenic or wildtype mice, is probably caused by the SREBP transgene, which is highly expressed only in fasting. Similarly, in Ϫ644-and Ϫ444-FAS-CAT͞SREBP double transgenic mice, CAT mRNA was induced in fasting to the same high level observed in refed single Ϫ644 and Ϫ444-FAS-CAT transgenic mice. In Ϫ278-FAS-CAT͞ SREBP transgenic mice, however, CAT mRNA expression was still increased in fasting because of the SREBP transgene expression, but only to the low level observed in the refed Ϫ278-FAS-CAT transgenic mice. On the other hand, the Ϫ131-FAS-CAT͞SREBP double transgenic mice did not show detectable CAT expression whether fasted or refed, indicating that deletion of the promoter sequence from Ϫ278 to Ϫ131 caused complete loss of CAT induction by SREBP transgene. As mentioned above, we used multiple founder lines and obtained similar results. This fact could be expected given the similar copies of incorporated transgene for Ϫ2.1, Ϫ644, Ϫ444, and Ϫ278 FAS-CAT. Even at higher copies of the transgene, the Ϫ131 FAS-CAT did not show any promoter activity, which indicates that the region up to Ϫ131 does not contain the site(s) sufficient for activation of the FAS promoter by SREBP and that sequences between Ϫ278 and Ϫ131 are required for FAS activation by SREBP. Interestingly, upon sequence examination, we found a consensus SRE at Ϫ150, although its function is unknown. As we have shown previously, however, an upstream regulatory region between Ϫ444 and Ϫ278, probably via USF binding to the Ϫ332 E-box, is responsible for the maximal increase in CAT expression similar to that observed in the endogenous FAS gene during feeding.
Transactivation of the FAS Promoter by SREBP in 3T3-L1 Fibroblasts.
To demonstrate the role of the FAS promoter region between Ϫ278 and Ϫ131 in the regulation of the FAS gene by SREBP in vitro, we carried out transactivation studies of the FAS promoter in 3T3-L1 cells. The 2.1-kb FAS promoter was activated by a truncated active form of SREBP-1a (15) in a dose-dependent manner, and we used 25 ng of SREBP expression vector per 60-mm dish that gave on separate transfections 8-to 15-fold activation, which falls within the linear range of response (data not shown). To determine the region required for activation by SREBP, we cotransfected various constructs carrying 5Ј deletion fragments ranging from Ϫ2100 to Ϫ136 fused to the LUC reporter gene along with the SREBP expression vector into 3T3-L1 cells. The Ϫ19 FAS-LUC was activated by SREBP slightly, probably because of cryptic SREBP binding site(s) in the vector itself because there is no significant element of the FAS promoter present in this construct. On the other hand, all of the FAS-LUC constructs, except Ϫ19 FAS-LUC, showed a similar degree of activation by SREBP, approximately 13-fold, suggesting the presence of a SRE between Ϫ136 and Ϫ19 of the FAS promoter (Fig. 3A) . Because our transgenic mice experiments shown in Fig. 2 clearly demonstrate requirement of the region between Ϫ278 and Ϫ131 for SREBP function, it may be speculated that, in in vitro cotransfection studies, SREBP may activate and increase reporter activity if any single putative binding site is present, regardless of its physiological relevance. In this regard, previous in vitro studies reported that SREBP can bind to the proximal FAS promoter region from Ϫ71 to Ϫ50 for sterol or insulin regulation (21, 23, 25) . On the other hand, we previously demonstrated that USF1͞USF2 binds to the E-box located in this region and mediates insulin regulation in 3T3-L1 adipocytes in culture (6) . We also found by site-directed mutagenesis of the sequences surrounding the Ϫ65 E-box that impaired SREBP binding had no effect on insulin regulation (6) . Nevertheless, these studies suggested to us that the binding of SREBP to the Ϫ65 region could have masked the function of the putative SRE located between Ϫ278 and Ϫ131. We therefore mutated the Ϫ65 E-box sequence, thereby preventing SREBP binding (data not shown), within the context of the 2.1-kb FAS promoter. When we used the mutated reporter construct and the SREBP expression vector, FAS promoter was still activated to the same extent as the wild-type construct (Fig. 3B) , suggesting the presence of other cis-acting regulatory sequences for SREBP. In addition, we tested the effect of Ϫ65 E-box mutation on the shorter Ϫ444, Ϫ184, and Ϫ136 FAS promoter context. Deletion of the FAS promoter up to Ϫ184 bp in the presence of the Ϫ65 mutation showed the same level of activation by SREBP as in Ϫ2100 FAS promoter. On the other hand, the SREBP activation was diminished to the level observed in the control Ϫ19 FAS-LUC when Ϫ136 FAS promoter containing the Ϫ65 mutation was used (Fig. 3B) . This finding clearly demonstrates that deletion of sequences between Ϫ184 and Ϫ136 prevented FAS promoter activation by SREBP and, therefore, the presence of a response element for SREBP in this region. These in vitro Fig. 2 . Regulation by fasting͞refeeding of CAT mRNA expression driven by the various FAS promoter regions. Total RNA isolated from liver was subjected to RNase protection assay to determine CAT, FAS, and actin mRNA levels as described in Materials and Methods and exposed to x-ray film (Fuji) for 1 day.
* represents an autoradiogram on BioMax film (Kodak) exposed for 3 days, and F and R indicate fasted and refed states, respectively. Essentially the same results were obtained from three independent experiments. studies demonstrating functional SREBP site between Ϫ136 and Ϫ184 support the in vivo results obtained in FAS-CAT͞SREBP double transgenic mice in Fig. 2 . We conclude that a functional SRE is present between Ϫ184 and Ϫ136.
SREBP Activates the FAS Promoter via the SRE Located at ؊150. When we inspected the FAS promoter sequence from Ϫ184 to Ϫ136 for possible SREBP binding sites, we found a canonical SRE located between Ϫ150 and Ϫ141 bp. Interestingly, comparison among rat, human, and goose FAS promoter sequences indicates that this potential SRE is highly conserved among species, suggesting a potential role in the regulation of the FAS gene. This site has been previously reported to have a negative effect on the FAS promoter activity (33) . To determine the potential function of the putative Ϫ150 SRE, we first examined the ability of SREBP to effectively bind this region by gel mobility shift assays. As shown previously, in vitro-transcribed and -translated SREBP-1a could bind oligonucleotides containing the Ϫ65 sequence effectively (Fig. 4) . SREBP also was able to bind to oligonucleotides containing the Ϫ150 SRE. The protein-DNA complex formed was sequence-specific because its formation was blocked by competition with excess unlabeled oligonucleotides, whereas cold oligonucleotides bearing a mutated SRE were unable to compete. In addition, SREBP-1 antibody supershifted the band, indicating the presence of SREBP-1 in the Ϫ150 SRE-protein complex. Although we have previously described the function of USF at the Ϫ332 E-box, because SREBP can bind not only SRE but also E-box sequence (22), we further examined the possible function of SREBP at the Ϫ332 E-box. If this were the case, SREBP binding to the Ϫ332 E-box could be responsible for the maximal induction of FAS gene expression observed in the transgenic mice (9) . In gel mobility shift assays, SREBP was able to bind to oligonucleotides containing the Ϫ332 E-box in a sequence-specific manner. Cold oligonucleotides were effective as a competitor (Fig. 4) . To demonstrate the requirement of E-box for binding of SREBP to this sequence, we mutated the overlapping inverted repeat of an E-box present in this sequence. Oligonucleotides carrying this mutation were not effective as a competitor. SREBP-1 antibody supershifted the band, indicating the presence of SREBP-1 in the Ϫ332 SRE-protein complex. The SREBP binding to the Ϫ332 or Ϫ65 E-box, however, was 4 . Binding of SREBP-1a to the Ϫ150 SRE of the FAS promoter. Gel shift assay was performed with in vitro-translated SREBP-1a as described in Materials and Methods. Each reaction contained 0.1 g of poly(dI-dC), 1 mM DTT, 0.1 ng of 32 P-labeled oligonucleotide probe (the Ϫ65 E-box probe in lanes 1-3, Ϫ150 SRE probe in lanes 4 -10, and Ϫ332 E-box probe in lanes [11] [12] [13] [14] [15] [16] [17] [18] [19] , and cold wild-type and mutant oligonucleotides of Ϫ150 SRE and Ϫ332 E-box probes (lanes 6 -9 and 13-16, respectively) as competitors. Lanes 1, 4, 11, and 17 are with unprogrammed control lysates, and lanes 2, 3, 5-10, 12-16, 18, and 19 are with in vitro-translated SREBP-1a. SREBP-1 antibody (lanes 3, 10, and 19) was added during the final 30 min of the DNA-protein complex formation for supershifting. N.S., nonspecific protein-DNA complex. weaker than the binding observed with the Ϫ150 SRE sequence (data not shown).
To examine specifically the contribution of the SREBP binding to the Ϫ150 SRE in the activation of the FAS promoter, we generated various FAS promoter-reporter constructs bearing single or double combinatorial mutations of the Ϫ65, Ϫ150, and Ϫ332 response elements. We tested the effects of these mutations in SREBP-1a function by transient cotransfection into 3T3-L1 cells. Our hypothesis is that a single potential SRE is sufficient for SREBP effect in transfection studies. As shown in Fig. 5 , single mutations at either Ϫ65 or Ϫ332 E-boxes or a mutation at Ϫ150 SRE did not abolish transactivation of the FAS promoter by SREBP. Only when the FAS promoter carried mutations in both the Ϫ65 E-box and the Ϫ150 SRE was transactivation by SREBP abolished. We next showed that the Ϫ150 SRE is sufficient for activation by SREBP. A single copy of Ϫ150 SRE conferred 3-fold activation to a heterologous promoter by SREBP whereas six copies conferred 23-fold activation (Table 1 ). It appears that, in in vitro studies, either the Ϫ65 sequence or the Ϫ150 SRE can mediate full activation of the FAS promoter by SREBP, but our in vivo studies clearly demonstrate requirement of a functional SRE between Ϫ278 and Ϫ131. We therefore conclude that SREBP binding to the Ϫ150 SRE sequence contributes to the activation of the FAS promoter during feeding. It may be that, in in vitro transfection assays, SREBP could bind and transactivate the FAS promoter as long as a single potential SRE site exists, either the Ϫ65 or Ϫ150 sequence. Mutations at both sites, however, clearly demonstrate the significance of the Ϫ150 SRE in these in vitro studies. Furthermore, double mutation of Ϫ65 and Ϫ332 Eboxes could not abolish transactivation of the FAS promoter by SREBP. These studies show that SREBP binding to the Ϫ332 E-box has no functional role in FAS regulation by SREBP and further support our previous report of USF function at the Ϫ332 E-box (9).
In conclusion, our present transgenic mice studies in combination with transient transfection assays suggest that FAS promoter activation by SREBP occurs via the Ϫ150 SRE during nutritional regulation of the FAS gene. The fact that the SREBP level is increased by feeding supports these conclusions. Our present model is that during fasting SREBP is limiting, which prevents activation of the FAS promoter. During refeeding, the SREBP level is increased and by binding to the Ϫ150 SRE, in combination with USF binding to the Ϫ332 E-box, causes maximal activation of the FAS promoter. Transgenic mice bearing mutations of each of these sites at the FAS promoter will provide unequivocal evidence for this model. 
